Evidence mapPaperPMID 41799939Full record

ArticleExploratory research in clinical and social pharmacy2026

A cross-sectional curvey study on the correlation between irrational drug use in diabetic patients and the occurrence of malignant tumors.

Lili Hu, Mengjiao Wang, Haiqing Zhou, Tao Wang, Juan Wen, Qian Li, Wei Jin, Nan Zhou

Abstract read
In one paragraph

Article in Exploratory research in clinical and social pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lili HuDepartment of Pharmacy, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Mengjiao WangCollege of Pharmacy, Xuzhou Medical University, Xuzhou, China.
Haiqing ZhouCollege of Pharmacy, Xuzhou Medical University, Xuzhou, China.
Tao WangDepartment of Pharmacy, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Juan WenMedical Records Department, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Qian LiDepartment of Medical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Wei JinCollege of Pharmacy, Xuzhou Medical University, Xuzhou, China.
Nan ZhouCollege of Pharmacy, Xuzhou Medical University, Xuzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: With an increase in morbidity of patients with type 2 diabetes mellitus (T2DM), to investigate the impact of inadequate prescription practices and medication habits on tumor-related risk factors. Methods: We analyzed data from 2114 patients with T2DM treated at our hospital from January 2019 to September 2022. The Medication Adherence Report Scale-5 items (MARS-5) and medication possession ratio (MPR) were used to assess medication use. Variables considered included diabetes duration, glycated hemoglobin (HbA1c) level, hypoglycemic drug regimens, and instances of irrational drug use. Univariate analysis and multivariate logistic regression were employed to identify risk factors associated with drug use in both the tumor and control groups, with a specific focus on lung cancer. Results: A total of 766 (36.23%) malignant tumors were identified, including 257 (33.55%) in the respiratory system, with 246 (32.11%) cases of lung cancer. Univariate analysis revealed that the use of insulin, combination of metformin with insulin and other oral hypoglycemic agents (OHAs), and instances of irrational drug use were significantly associated with malignant tumors in patients with T2DM ( Conclusion: Irrational drug use is a significant risk factor for the development of malignant tumors, particularly lung cancer, is't correlated with abnormal HbA1c levels.

Indexed as

HbA1cIrrational drug useLung cancerRisk factorsType 2 diabetes mellitus

Identifiers

PMID41799939
PMCPMC12964049

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.